IL17A and Cognitive impairment: In one study, neonatal mice exposed to sevoflurane showed increased IL-17A expression in the hippocampus; deletion or inhibition of IL-17A attenuated sevoflurane-induced cognitive impairment by reducing hippocampal neuroinflammation (20).